Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bio-Rad Laboratories, Inc. et al v. 10X Genomics, Inc.
Case Number:
1:19-cv-12533
Court:
Nature of Suit:
Judge:
Firms
- Birnbaum & Godkin
- BraunHagey & Borden
- Brown Rudnick
- Cleary Gottlieb
- Foley & Lardner
- McDermott Will & Emery
- Neufeld Scheck
- Orrick Herrington
- Sullivan & Worcester
- Tensegrity Law
- Weil Gotshal
Companies
Sectors & Industries:
-
July 27, 2021
Bio-Rad And 10X Agree To End Patent War
Biotech rivals 10X Genomics and Bio-Rad Laboratories Inc. said Tuesday that they had reached a deal to end their many legal fights over competing DNA technology, less than a week before the two California companies were set to spar again in front of a jury in Delaware.
-
June 10, 2021
IP Forecast: Amazon To Face A Texas Jury Over Voice IP
Amazon is set to be the next tech titan to appear in front of the busiest patent judge in the country as U.S. District Judge Alan Albright is scheduled to kick off a jury trial over claims Alexa infringes voice technology patents owned by an Israeli kitchen technology startup. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
June 04, 2021
Bio-Rad Tries To Keep 10X From Talking Up Pandemic At Trial
Bio-Rad has told a Massachusetts federal judge that any mention of the ongoing COVID-19 pandemic at next month's jury trial over its patented DNA technology would be "highly inflammatory," accusing 10X of trying to overstate the "alleged importance" of 10X's own scientific research.
-
December 10, 2020
10X Calls Fraud In Latest Effort To Dodge $24M Jury Verdict
Bio-Rad Laboratories Inc. hasn't kept its stories straight about how much its patented DNA technology is really worth, rival 10X Genomics Inc. said Thursday in alleging that a Delaware federal jury's nearly $24 million infringement verdict against 10X was obtained through fraud and lies.
-
August 31, 2020
Bio-Rad Gets 10X Genomics' Antitrust Claims Trimmed
Bio-Rad Laboratories Inc. was dealt a partial victory in its patent dispute against life sciences company 10X Genomics Inc. when a Massachusetts federal judge on Monday whittled down some antitrust counterclaims Bio-Rad had called "implausible."
-
April 30, 2020
10X Genomics Must Face Bio-Rad, Harvard Patent Suit
Life sciences company 10x Genomics Inc. lost a bid on Thursday to nix a patent case brought by Bio-Rad Laboratories Inc. and Harvard University, though the court did grant 10x Genomics' request to move part of the litigation from federal court in Massachusetts to California.